ARTICLE | Company News
MEDX antibody deal with Seattle Genetics
February 7, 2001 8:00 AM UTC
Medarex (MEDX) and Seattle Genetics (Bothell, Wash.) will develop cancer antibodies using MEDX's UltiMAb human antibody development system and Seattle Genetics' cancer targets. The companies will shar...